We surveyed US and Canadian physicians to uncover which medical conferences deliver the most value and which fall short. Interestingly, high attendance doesn’t always mean high perceived value, with key exceptions in cardiology and oncology specialties.
This infographic illuminates which conferences rank the highest in attendance and value across prominent medical specialties.
In this study, we explore the perceptions of US and Canadian physicians on conference attendance and CHE/CME events.
The results highlight that while virtual events have become common, in-person conferences continue to provide significantly more value. Physicians prioritize interactive elements such as Q&A sessions, panel discussions, and case-based workshops, which enhance engagement and learning. The study also reveals the key factors that influence physicians’ attendance, satisfaction, and what they expect from pharmaceutical companies to create a valuable conference experience.
Discover more in our detailed infographic.
Physicians are spending, on average, two hours a day using websites and social media for professional purposes. The increasing reliance on digital media is transforming how physicians engage with crucial product information.
This infographic delves into the insights of our most recent study, exploring which social media channels physicians prefer for professional use, their perceived appropriateness, and the platforms where they welcome interactions with pharmaceutical companies.
In the rapidly evolving landscape of healthcare, the role of digital tools and media in the professional lives of healthcare professionals is only growing. Physicians now accept less than half of pharma reps’ requests for meetings. As these in-person interactions decline, the need for effective digital information channels becomes crucial.
Our latest infographic illuminates who physicians view as leaders in the digital media space, and what factors influence these perceptions.
Since its initial onset, COVID-19 has had a significant impact on how physicians interact with pharmaceutical companies. Government restrictions forced companies to quickly adapt and move to more remote forms of interactions. While in-person interactions are once again a viable option for communication, will they return to pre-pandemic levels? MD Analytics has been monitoring these trends over the past few years and we have recently interviewed 50 Canadian GPs and 90 Canadian specialists in our latest survey on the topic.
While the vaccination campaign in Canada has shown positive progress, the COVID-19 pandemic continues to significantly impact the way in which HCPs interact with both patients and pharma. MD Analytics has been monitoring these trends over the past year and we are excited to share with you our 4th wave infographic on this topic.
For the first time since initiating this tracking study, patient volumes have returned back to pre-pandemic conditions, as have key measures such are diagnostic tests performed and treatment switches. It is important to note that while most physicians feel that their workloads are now similar to pre-COVID conditions, many expect to exceed their current levels in the coming months.
Our 5-minute online survey conducted in the fall of 2020 sought to gain clarity around remote detailing. This study was conducted with 339 Canadian physicians who are members of the MD Analytics healthcare panel and the results provide actionable recommendations on how to form a more ‘ideal’ pharma remote detail.
In October 2018, the use of recreational cannabis was legalized across Canada. Looking back at the past year, physicians remain divided in their views towards this new legislation, though support skews towards younger GPs. This legislation has impacted the use of prescription treatments and patient visits in a number of key therapeutic areas, though not to the degree that was anticipated 12 months ago.
Over a 3-day period, MD Analytics surveyed 1,000 Canadians that are responsible for making health-related decisions. It was found that respondents are often choosing to not to see a physician when health-related scenarios arise, citing self-diagnosis or lack of convenience as their key reasons. Respondents are also strongly likely to visit a walk-in clinic instead of their family physician, with convenience again mentioned as the key reason.
The Canadian Senate recently passed Bill C-46 which will allow for the legal use of recreational cannabis across Canada by Fall 2018. While some physicians anticipate this new legislation will impact their practices with patients electing to try recreational cannabis instead of more traditional prescription medications or medical cannabis, others anticipate increases in patient visits related to dependence and psychotic symptoms.
With the emergence of Complementary and Alternative Medicine (CAM), prescription options alone are no longer the norm as it pertains to treating a number of medical conditions. Research among 170 Canadian physicians shows that CAM therapies are not only common practice for many already, but are expected to become even more widely accepted as viable treatment options within the conventional medical community.
Modern Blood Glucose Meter (BGM) devices can often pair with a companion app on a smartphone, which allows patients to easily record and monitor their blood glucose levels over time. This gives the patient, and potentially their doctor, easy to access historical data, insightful charts, and other information that can aid in diabetes management. Research was conducted by MD Analytics to assess whether Canadian GPs are accepting this technology, and if it plays a role in their recommendation of one BGM over another.